Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Pancreatic Neoplasms 6Prostatic Neoplasms 4Nasopharyngeal Carcinoma 4Carcinoma, Hepatocellular 4Radiation Injuries 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Melanoma 2Carcinoma 2Vulvar Neoplasms 1Uterine Cervical Neoplasms 1Triple Negative Breast Neoplasms 1Thymoma 1Thymic epithelial tumor 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Rectal Neoplasms 1Rare Diseases 1Pancreatic Cancer Non-resectable 1Ovarian Neoplasms 1Osteosarcoma 1Neoplasms 1Meningioma 1Locally Advanced Pancreatic Cancer 1Glioma 1Chondrosarcoma 1Carcinoma, Transitional Cell 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Drug Therapy 2Cyclophosphamide 2toripalimab 1pembrolizumab 1fludarabine 1apatinib 1TP protocol 1Surgical Procedures, Operative 1Radiation 1Immunotherapy 1Heavy Ion Radiotherapy 1Doxorubicin 1Cisplatin 1Carboplatin 1AP 1903 reagent 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymic epithelial tumor × Heavy Ion Radiotherapy × Clear all
NCT06311955 2025-06-13

Clinical Study of Postoperative Carbon Ion Radiotherapy for Thymus Tumor With Residual Tumor

Shanghai Proton and Heavy Ion Center

Phase 2 Recruiting
48 enrolled

Thymic epithelial tumor, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡